1. Home
  2. RDWR vs COLL Comparison

RDWR vs COLL Comparison

Compare RDWR & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDWR
  • COLL
  • Stock Information
  • Founded
  • RDWR 1996
  • COLL 2002
  • Country
  • RDWR Israel
  • COLL United States
  • Employees
  • RDWR N/A
  • COLL N/A
  • Industry
  • RDWR EDP Services
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDWR Technology
  • COLL Health Care
  • Exchange
  • RDWR Nasdaq
  • COLL Nasdaq
  • Market Cap
  • RDWR 889.9M
  • COLL 910.2M
  • IPO Year
  • RDWR 1999
  • COLL 2015
  • Fundamental
  • Price
  • RDWR $22.18
  • COLL $30.00
  • Analyst Decision
  • RDWR Hold
  • COLL Strong Buy
  • Analyst Count
  • RDWR 4
  • COLL 5
  • Target Price
  • RDWR $27.00
  • COLL $43.60
  • AVG Volume (30 Days)
  • RDWR 131.8K
  • COLL 444.8K
  • Earning Date
  • RDWR 05-07-2025
  • COLL 05-08-2025
  • Dividend Yield
  • RDWR N/A
  • COLL N/A
  • EPS Growth
  • RDWR N/A
  • COLL 43.56
  • EPS
  • RDWR 0.14
  • COLL 1.86
  • Revenue
  • RDWR $274,880,000.00
  • COLL $631,449,000.00
  • Revenue This Year
  • RDWR $9.54
  • COLL $20.00
  • Revenue Next Year
  • RDWR $7.54
  • COLL $3.93
  • P/E Ratio
  • RDWR $154.93
  • COLL $16.09
  • Revenue Growth
  • RDWR 5.20
  • COLL 11.41
  • 52 Week Low
  • RDWR $16.12
  • COLL $27.28
  • 52 Week High
  • RDWR $25.00
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • RDWR 48.72
  • COLL 51.96
  • Support Level
  • RDWR $21.46
  • COLL $29.01
  • Resistance Level
  • RDWR $23.37
  • COLL $30.53
  • Average True Range (ATR)
  • RDWR 0.58
  • COLL 0.89
  • MACD
  • RDWR -0.03
  • COLL 0.04
  • Stochastic Oscillator
  • RDWR 50.62
  • COLL 62.91

About RDWR Radware Ltd.

Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. The company generates maximum revenue from the United States.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: